If you have seen those GLP-1 shelves at the pharmacy, Haleon wants its brands front and center. The London-listed consumer health company said it is seeing growing U.S. sales tied to products that help with side effects as GLP-1 use spreads. The drugs called out include Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo, which aid weight loss by copying a hormone that signals fullness.
Popular as they are, GLP-1s can come with downsides. Reported side effects include nausea, vomiting, constipation and diarrhea, and some users also report abdominal pain and stomach cramps. That is the demand Haleon is aiming to meet.
Haleon - the company behind Advil pain relief as well as Biotène oral-care gels and TUMS indigestion tablets - said it is working with U.S. retailers including CVS Pharmacy to place its products both on regular aisles and in dedicated GLP-1 sections. "Dual placement in core aisles and GLP-1 destination sets delivers an average 24% sales lift per store," a Haleon spokesperson said, noting the increase was recorded in Q1. The spokesperson added, "Haleon holds the majority of GLP-1 shelf space at CVS," and said items grouped on those GLP-1 shelves are outperforming the same products in stores without a dedicated set.
CVS Pharmacy said it "has expanded its product assortment and is highlighting CVS brand and national brand over-the-counter products to help make managing side effects easier," without addressing Haleon's comments directly. Beyond CVS, Haleon said it has also discussed its GLP-1 in-store strategy with Walmart and Target, without sharing how those talks ended. Demand is sizable: Gallup reports that about 11% of Americans are taking GLP-1 weight-loss medications.
When consumer needs shift, steady financial habits help protect and grow your savings. Join Briefs Finance CEO Jaspreet Singh on September 29th for a FREE live investor workshop, How to Profit From A Dollar That's Losing its Value, where he shows how we're spotting investment opportunities as the dollar falls. Save your spot.
If more shoppers are grabbing relief aids alongside GLP-1 prescriptions, shelf space becomes strategy, and strategy can show up in sales. For everyday budgets, it is a reminder that new health trends often pull related categories along with them, from pain relief to digestive care. Watching where retailers carve out special sections can be a simple tell for what could keep moving off the shelves next.
Watching trends in everyday spending can guide thoughtful steps to preserve wealth. Our CEO Jaspreet Singh is hosting a FREE live investor workshop, How to Profit From A Dollar That's Losing its Value, on September 29th. Sign up free to join him live.
